Fei Zhou, Huanjie Li, Fei Wang, Liyuan Liu, Lixiang Yu, Yujuan Xiang, Chao Zheng, Shuya Huang, Zhigang Yu
OBJECTIVES: To assess the efficacy and safety of rifampicin-based triple therapy (rifampicin, isoniazid and ethambutol) for treating NPM. METHODS: This single-center, single-arm, prospective clinical trial was conducted at the Second Hospital of Shandong University (Jinan, China). Patients with pathologically diagnosed granulomatous lobular mastitis and periductal mastitis received triple drugs, i.e., rifampicin (450 mg/day), isoniazid (300 mg/day) and ethambutol (15 mg/kg/day), until complete response or the investigator decided to discontinue treatment...
December 22, 2023: International Journal of Infectious Diseases: IJID